Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: Lessons from the DALI Study

International Journal of Antimicrobial Agents

Volumn 43, Issue 5, 2014, Pages 423-430

  Roberts, J A ^a,b   Stove, V ^c   De Waele, J J ^c   Sipinkoski, B ^d   McWhinney, B ^d   Ungerer, J P J ^d   Akova, M ^e   Bassetti, M ^f   Dimopoulos, G ^g   Kaukonen, K M ^h,i   Koulenti, D ^a,g   Martin, C ^j,k   Montravers, P ^l   Rello, J ^m   Rhodes, A ⁿ   Starr, T ^b   Wallis, S C ^b   Lipman, J ^a,b   Paul, S ^o   Ribas, A M ^o   DeCrop, L ^o   Spapen, H ^o   Wauters, J ^o   Dugernier, T ^o   Jorens, P ^o   Dapper, I ^o   De Backer, D ^o   Taccone, F S ^o   Ruano, L ^o   Afonso, E ^o   Alvarez Lerma, F ^o   Gracia Arnillas, M P ^o   Fernandez F ^o   Feijoo, N ^o   Bardolet, N ^o   Rovira, A ^o   Garro, P ^o   Colon, D ^o   Castillo, C ^o   Fernado, J ^o   Lopez, M J ^o   Fernandez, J L ^o   Arribas, A M ^o   Teja, J L ^o   Ots, E ^o   Montejo, J C ^o   Catalan, M ^o   Prieto, I ^o   Gonzalo, G ^o   Galvan, B ^o   Blasco, M A ^o   Meyer, E ^o   Nogal, F D ^o   Vidaur, L ^o   Sebastian, R ^o   Garde, P M ^o   Velasco Mdel, M ^o   Crespo, R Z ^o   Esperatti, M ^o   Torres, A ^o   Baldesi, O ^o   Dupont, H ^o   Mahjoub, Y ^o   Lasocki, S ^o   Constantin, J M ^o   Payen, J F ^o   Albanese, J ^o   Malledant, Y ^o   Pottecher, J ^o   Lefrant, J Y ^o   Jaber, S ^o   Joannes Boyau, O ^o   Orban, C ^o   Ostermann, M ^o   McKenzie, C ^o   Berry, W ^o   Smith, J ^o   Lei, K ^o   Rubulotta, Francesca ^o   Gordon, A ^o   Brett, S ^o   Stotz, M ^o   Templeton, M ^o   Ebm, C ^o   Moran, C ^o   Pettila V ^o   Xristodoulou, A ^o   Theodorou, V ^o   Kouliatsis, G ^o   Sertaridou, E ^o   Anthopoulos, G ^o   Choutas, G ^o   Rantis, T ^o   Karatzas, S ^o   Balla, M ^o   Papanikolaou, M ^o   Myrianthefs, P ^o   Gavala, A ^o   Fildisis, G ^o   Koutsoukou, A ^o   Kyriakopoulou, M ^o   Petrochilou, K ^o   Kompoti, M ^o   Michalia, M ^o   Clouva Molyvdas, F M ^o   Gkiokas, G ^o   Nikolakopoulos, F ^o   Psychogiou, V ^o   Malliotakis, P ^o   Akoumianaki, E ^o   Lilitsis, E ^o   Koulouras, V ^o   Nakos, G ^o   Kalogirou, M ^o   Komnos, A ^o   Zafeiridis, T ^o   Chaintoutis, C ^o   Arvaniti, K ^o   Matamis, D ^o   Kydona, C ^o   Gritsi Gerogianni, N ^o   Giasnetsova, T ^o   Giannakou, M ^o   Soultati, I ^o   Chytas, I ^o   Antoniadou, E ^o   Antipa, E ^o   Lathyris, D ^o   Koukoubani, T ^o   Paraforou, T ^o   Spiropoulou, K ^o   Bekos, V ^o   Spring, A ^o   Kalatzi, T ^o   Nikolaou, H ^o   Laskou, M ^o   Strouvalis, I ^o   Aloizos, S ^o   Kapogiannis, S ^o   Soldatou, O ^o   Adembri, C ^o   Villa, G ^o   Giarratano, A ^o   Raineri, S M ^o   Cortegiani, A ^o   Montalto, F ^o   Strano, M T ^o   Ranieri, V M ^o   Sandroni, C ^o   De Pascale, G ^o   Molin, A ^o   Pelosi, P ^o   Montagnani, L ^o   Urbino, R ^o   Mastromauro, I ^o   DeRosa, F G ^o   Cardoso, T ^o   Afonso, S ^o   Goncalves Pereira J ^o   Baptista, J P ^o   Ozveren A ^o   more..

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d Queensland Pathology Services   (Australia)

^e HACETTEPE UNIVERSITY   (Turkey)

^f SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^g NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^h HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

ⁱ MONASH UNIVERSITY   (Australia)

^j HÔPITAL NORD   (France)

^k AzuRea Group   (France)

^l BICHAT HOSPITAL   (France)

^m UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

ⁿ ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^o NONE

more..

Author keywords

Antibiotics; Critically ill patients; Glycopeptides; Hypoalbuminaemia; ICU; Pharmacokinetics

Indexed keywords

TEICOPLANIN; ANTIINFECTIVE AGENT; PROTEIN BINDING;

ADULT; AGED; ANTIBIOTIC THERAPY; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CALIBRATION; CLINICAL ARTICLE; CRITICALLY ILL PATIENT; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSE REGIMEN; DRUG HALF LIFE; DRUG MONITORING; DRUG PROTEIN BINDING; DRUG PROTEIN BINDING VARIABILITY; ENTEROCOCCAL INFECTION; FEMALE; FREE PLASMA DRUG CONCENTRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MID DOSE CONCENTRATION; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; STAPHYLOCOCCUS INFECTION; STEADY STATE; TROUGH TIME CONCENTRATION; ULTRAVIOLET SPECTROSCOPY; VALIDATION PROCESS; VALIDITY; CHEMISTRY; CHROMATOGRAPHY; CLINICAL TRIAL; CRITICAL ILLNESS; INTERNATIONAL COOPERATION; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PLASMA; YOUNG ADULT;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CHROMATOGRAPHY; CRITICAL ILLNESS; DRUG MONITORING; FEMALE; HUMANS; INTERNATIONAL COOPERATION; MALE; MIDDLE AGED; PLASMA; PROTEIN BINDING; TEICOPLANIN; YOUNG ADULT;

EID: 84899530823     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2014.01.023     Document Type: Article

References (24)

1. M.E. Stryjewski, and G.R. Corey Methicillin-resistant Staphylococcus aureus: an evolving pathogen Clin Infect Dis 58 Suppl. 1 2014 S10 S19
2. J.L. Vincent, J. Rello, J. Marshall, E. Silva, A. Anzueto, and C.D. Martin et al. International study of the prevalence and outcomes of infection in intensive care units J Am Med Assoc 302 2009 2323 2329
3. H.M. Ziglam, and R.G. Finch Limitations of presently available glycopeptides in the treatment of Gram-positive infection Clin Microbiol Infect 7 Suppl 4 2001 53 65 (Pubitemid 34966108)
4. J.R. Lentino, M. Narita, and V.L. Yu New antimicrobial agents as therapy for resistant Gram-positive cocci Eur J Clin Microbiol Infect Dis 27 2008 3 15 (Pubitemid 350197870)
5. F. Alvarez-Lerma, and S. Grau Management of antimicrobial use in the intensive care unit Drugs 72 2012 447 470
6. M.J. Rybak, B.M. Lomaestro, J.C. Rotschafer, R.C. Moellering, W.A. Craig, and M. Billeter et al. Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists Clin Infect Dis 49 2009 325 327
7. J.A. Roberts, J.J. De Waele, G. Dimopoulos, D. Koulenti, C. Martin, and P. Montravers et al. DALI: Defining Antibiotic Levels in Intensive care unit patients: a multi-centre point of prevalence study to determine whether contemporary antibiotic dosing for critically ill patients is therapeutic BMC Infect Dis 12 2012 152
8. J.A. Roberts, R. Norris, D.L. Paterson, and J.H. Martin Therapeutic drug monitoring of antimicrobials Br J Clin Pharmacol 73 2012 27 36
9. R. Yano, T. Nakamura, H. Tsukamoto, T. Igarashi, N. Goto, and Y. Wakiya et al. Variability in teicoplanin protein binding and its prediction using serum albumin concentrations Ther Drug Monit 29 2007 399 403 (Pubitemid 47220455)
10. S. Finfer, S. McEvoy, R. Bellomo, C. McArthur, J. Myburgh, and R. Norton et al. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis Intensive Care Med 37 2011 86 96
11. M. Ulldemolins, J.A. Roberts, J. Rello, D.L. Paterson, and J. Lipman The effects of hypoalbuminaemia on optimising antibiotic dosing in critically ill patients Clin Pharmacokinet 50 2011 1 12
12. M. Ulldemolins, J.A. Roberts, J. Lipman, and J. Rello Antibiotic dosing in multiple organ dysfunction syndrome Chest 139 2011 1210 1220
13. A.P. Wilson Clinical pharmacokinetics of teicoplanin Clin Pharmacokinet 39 2000 167 183
14. J.A. Roberts, F. Pea, and J. Lipman The clinical relevance of plasma protein binding changes Clin Pharmacokinet 52 2013 1 8
15. J. Lipman, A.A. Udy, and J.A. Roberts Do we understand the impact of altered physiology, consequent interventions and resultant clinical scenarios in the intensive care unit? The antibiotic story Anaesth Intensive Care 39 2011 999 1000
16. A.A. Udy, J.A. Roberts, R.J. Boots, D.L. Paterson, and J. Lipman Augmented renal clearance: implications for antibacterial dosing in the critically ill Clin Pharmacokinet 49 2010 1 16
17. A.A. Udy, J.A. Roberts, and J. Lipman Implications of augmented renal clearance in critically ill patients Nat Rev Nephrol 7 2011 539 543
18. J.A. Roberts, S.K. Paul, M. Akova, M. Bassetti, J.J. De Waele, and G. Dimopoulos et al. DALI: Defining Antibiotic Levels in Intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients? Clin Infect Dis 2014 [Epub ahead of print]
19. I. Harding, A.P. MacGowan, L.O. White, E.S. Darley, and V. Reed Teicoplanin therapy for Staphylococcus aureus septicaemia: relationship between pre-dose serum concentrations and outcome J Antimicrob Chemother 45 2000 835 841 (Pubitemid 30348955)
20. I. Bilgrami, J.A. Roberts, S.C. Wallis, J. Thomas, J. Davis, and S. Fowler et al. Meropenem dosing in critically ill patients with sepsis receiving high-volume continuous venovenous hemofiltration Antimicrob Agents Chemother 54 2010 2974 2978
21. R.F. Frye, M.L. Job, R.H. Dretler, and B.J. Rosenbaum Teicoplanin nephrotoxicity: first case report Pharmacotherapy 12 1992 240 242
22. A. Kureishi, P.J. Jewesson, M. Rubinger, C.D. Cole, D.E. Reece, and G.L. Phillips et al. Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicity Antimicrob Agents Chemother 35 1991 2246 2252
23. F. Pea, L. Brollo, P. Viale, F. Pavan, and M. Furlanut Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose J Antimicrob Chemother 51 2003 971 975 (Pubitemid 36503431)
24. M. Ulldemolins, J.A. Roberts, S.C. Wallis, J. Rello, and J. Lipman Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: special emphasis on unbound pharmacokinetics J Antimicrob Chemother 65 2010 1771 1778